- This event has passed.
The 7th International Cardiovascular Genomic Medicine Conference
December 4, 2019 - December 5, 2019
‘Clinical Cardiology in the Genome Era- From Genome Diagnosis to Therapy of Inherited Cardiovascular Diseases’
The Biennial ‘7th International Conference on Cardiovascular Genomic Medicine Conference’ offers a unique opportunity for clinical cardiologists, specialist cardiac nurses, electrophysiologists, cardiovascular radiologists, cardiac pathologists, clinical geneticists, genetic counselors and molecular geneticists to learn and share the fast emerging practice of cardiovascular genomic medicine.
World class Faculty of experts in all fields of cardiovascular genetics & genomics and genomic medicine will join the wide ranging participants from UK, Europe and rest of the World. The programme includes plenary lectures, keynote presentations, open platform and poster presentations and seminars on selected topics.
This conference is the 7th as part of the original series of Biennial ‘Cardiff Cardiovascular Genetics Conference’ held since 2007. All previous events were grand successes admired by several clinicians, health professionals and researchers from all over the world.
For Registration, Sponsorship and all other enquiries please visit www.genomicmedicine.org
www.eventbrite.co.uk
For General information and contributions to the Scientific Programme please contact Prof. Dhavendra Kumar
genomicmedicine@yahoo.co.uk
cardiovasculargeneticsgenomics@gmail.com
Scientific Programme
Scientific Committee
- Dhavendra Kumar (Cardiff, UK)- Chair
- Perry Elliott (London, UK)
- Bill Newman (Manchester, UK)
- Elijah Behr (London, UK)
- Arthur Wilde (Amsterdam, NL)
- Bart Loeys (Antwerp, Belgium)
- Robert Hamilton (Toronto, Canada)
- Ajay Bahl (Chandigarh, India)
- Lorenzo Monserrat (La Coruna, Spain)
- Ingrid Winship (Melbourne, Australia)
Day 1:
0800 Registration
0900 Welcome/ Introduction Dhavendra Kumar
0905 Session 1: ‘Phenotype-genotype ontology of inherited
cardiovascular conditions’
Chair: Professor Ruth New-Bury Ecob, Bristol, UK
0905 Congenital heart disease
Catherine Mercer, Clinical Genetics Unit, University of Southampton, UK
0920 Myocardium phenotypes
Diana Fatkin, University of Melbourne, Victoria, Australia
0940 Aortic & arterial phenotypes
Bart Loeys, University of Antwerp, Belgium
1000 Primary lymphatic anomalies- an update
Sahar Mansour, St. George’s Hospital, London, UK
1015 Role of Myocardin in smooth and cardiac muscle development
- Houweling, Molecular Cardiology Unit, Academic Medical Center, Amsterdam, The Netherlands
1030 Plenary 1:
‘Genomics led personalised prescribing in cardiovascular medicine’
Professor Sir Munir Primohamed, Liverpool, UK
Chair: Professor Patricia Munroe, QMUL, London, UK
1115 Tea/Coffee/Exhibitors
1145 Session 2: ‘Novel genes and molecules underpinning cardiomyopathies’
Chair: Professor Perry Elliott, UCL/Bart’s, London, UK
1145 Sarcomere- novel genes and related molecules
Lorenzo Monserrat, Cardiovascular Genomics Laboratory (HealthinCode), La Coruna, Spain
1205 MYH7 variant in Egyptian HCM patients
Mona Allouba, Aswan Heart Centre, Egypt
1220 Titin and related genes/molecules
James Ware, Imperial, University of London, UK
1240 Dystrophin & related molecules
Federica Montanaro, Great Ormond Street Hospital of Sick Children, London, UK
1300 LUNCH
1415 Session 3: ‘Heterogeneity of disorders of cardiac conduction & rhythm’
Chair: Dr. John Dean, Aberdeen, Scotland, UK
1415 Brugada syndrome- Mendelian, Oligogenic or Multigenic?
Elijah Behr, Cardiovascular Medicine, St. George’s, London, UK
1435 Genomic complexity of atrial fibrillation
Rui Providencia and Pier Lambiase, Cardiovascular Research Centre, University College of London, UK
1455 Whole genome and transcriptome sequencing of post-mortem cardiac tissues from sudden cardiac death victims
S.B. Jacobson, Section of Forensic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
1505 The Egyptian Collaborative Cardiac Genomics (ECCO-GEN): Defining a Healthy Volunteer Cohort
Yasmine Aguib, Aswan Heart Centre, Egypt
1520 TEA/ COFFEE/ POSTERS
1545 Plenary 2- Keynote Lecture: “The Sir William Harvey Oration” Life long pursuit of Inherited Cardiovascular Conditions
Professor Bill McKenna, Cardiovascular Medicine, University College London, London, UK
Introduction/ Citation by Professor Dhavendra Kumar
1645 Session 4: Clinical Cardiovascular Genomic Medicine
Chair: Professor Ajay Bahl, Chandigarh, India
1645 The Miles Frost Hypertrophic Cardiomyopathy Prevention- a model for Preventive (Community/Public Health) Cardiology
Morven Dunn & Joanne Whitmore, The British Heart Foundation, London, UK
1700 Outcomes of the next generation genome diagnosis for inherited cardiac conditions
Tessa Homfray, Clinical Genetics Unit, St.George’s Hospital, London, UK
1715 Hypertrophic Cardiomyopathy & Pregnancy Outcomes in North India
Pooja Sikka, Department of Obstetrics & Gynecology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
1730 Multi-Disciplinary team for delivering the NHS cardiovascular genomic medicine service
Gerry Carr-White, St. Thomas/ Guy’s Hospitals, London, UK
Reflections & Discussion on Day 1
1745 CLOSE
1800 Welcome Drinks Reception
1900 GALA DINNER
Day 2: 5th December 2019
0800-0830 Registration
0830 Session 5: ‘Genomic research applications in complex cardiovascular conditions’
Chair: Dr. Maite Tome, St. George’s, London, UK
0830 Polygenic score and complex cardiac conditions
Emanuale Di Angelantonio, University of Cambridge, UK
0850 Stroke genetics & genomics in clinical arena
Hugh Markus, Adenbrooke’s Hospital, University of Cambridge, UK
0910 Systemic Hypertension- outcomes of genomic studies
Patricia Munroe, The William Harvey Heart Centre, QMUL, London, UK
0930 Genomic insights in aortic & arterial diseases
Julie de Backer, University of Ghent Hospital, Belgium
1000 Plenary 3: ‘The Genomic Revolution in Pediatric Clinical Cardiology’
Prof. Seema Mittal, Sick Kids Hospital, Toronto, Ontario, Canada.
Chair: Dr. Juan Kaski, GOSH, London, UK
1100 Tea/Coffee/ Posters
1130 Session 6: ‘Cardiovascular Genomic Medicine Research’
Chair: Professor Elijah Behr, London, UK
1130 Validating electronic health records (EHR) cardiovascular phenotypes by the UK Phenomics platform
Tom Lumbers, University College London, UK
1150 Pertinent Issues in cardiovascular diagnostic genomic testing
Ellen Thomas, Genomics England, QMUL/Imperial, London, UK
1210 Challenge of variant classification in cardiovascular medicine: The example of hypertrophic cardiomyopathy
- Fokstuen, Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland
1230 Development of the Indian Inherited Cardiovascular Conditions Database
Ajay Bahl, Post Graduate Institute of Medical Education & Research, Chandigarh, India
1250- 1415 Poster viewing & Lunch
Session 7: ‘Novel genomic/molecular cardiovascular therapeutics approaches’
Chair: Professor Dhavendra Kumar, QMUL, London, UK
1415 Novel therapeutic advances in arrhythmogenic cardiomyopathy
Angeliki Asimaki, Cardiovascular Medicine, St. George’s, London, UK
1435 Novel therapeutic advances for hypertrophic cardiomyopathy
Rajaram Anananthraman, Dr. Cherian Heart Foundation, Chennai, India
1455 Stem cell and related therapeutic advances in hypertrophic cardiomyopathy
Matthew Daniels, Department of Cardiology, University of Oxford & University of Manchester, UK
1520 COFFEE/TEA
1530 Session 8: Open Presentations (selected from submitted abstracts)
Prize for best presentation
Panel of 3 judges Dr. Sarju Mehta, Cambridge, UK
Ms. Melanie Watson, Southampton, UK
Dr. Sam Mohaddin, Bart’s, London, UK
Note: 7 minutes including 2 minutes discussion
1530 Heart failure, severe arrhythmia and sudden cardiac death in Marfan syndrome
and related heritable thoracic aortic diseases
Anthony Demolder, Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
1540 Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers Danlos Syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility
Neeti Ghali, Ehlers-Danlos Syndrome National Diagnostic Service London, North West Thames Regional Genetics Service, London North West Healthcare University NHS Trust, Harrow, Middlesex, UK
1550 Genome sequencing for inherited cardiac conditions: analysis of 201 cardiovascular patients recruited through the 100,000 Genomes project by the West of England and South West NHS Genomic Medicine Centres.
Rebecca Whittington, Clinical Genetics, Bristol University Hospitals NHS Trust, Bristol, UK
1600 Major Genetic Contributors to Non-syndromic Tetralogy of Fallot
Richard Monaghan, Cardiovascular Medicine, University of Manchester, UK
1610 Identifying Long QT syndrome patients in primary care: A population- based case control study
WRH Evans, PRISM group, Division of Primary care, University of Nottingham, UK
1620 Biallelic PPP1R13L-associated paediatric dilated cardiomyopathy: expanding the phenotypic spectrum
Claire Turner, Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK
1630 Panel comments, summing up and the best presentation award
1635 Plenary 4: ‘Dilated Cardiomyopathies- new paradigms for cardiovascular genomic medicine’
Professor Perry Elliott, Director- Cardiovascular Research Institute, University College London and Lead Consultant Cardiologist of the Inherited Heart Diseases Unit, St. Bart’s Hospital, London, UK
Chair: Professor Nigel Wheeldon, Sheffield, UK
1715 Questions/ Reflections
1730 Prizes/ Vote of Thanks/ Close
Good Bye/ Bon voyage